Calza L, Bon I, Pensalfine G, Vitale S, et al. CHANGES IN SERUM INFLAMMATORY MARKERS IN ANTIRETROVIRAL THERAPY-NAIVE HIV-INFECTED PATIENTS STARTING DOLUTEGRAVIR/LAMIVUDINE OR TENOFOVIR ALAFENAMIDE/EMTRICITABINE/BICTEGRAVIR. J Acquir Immune Defic Syndr 2022 Aug 18. pii: 00126334-990000000-00095.
PMID: 35981265